Healthpeak Properties (DOC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
12 Mar, 2026Voting matters and shareholder proposals
Shareholders will vote on the election of nine director nominees for the board for the upcoming term.
Advisory approval of 2025 executive compensation is on the agenda.
Ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the year ending December 31, 2026, will be considered.
Proxies may vote on other business that arises during the meeting or any adjournments.
Board of directors and corporate governance
Nine individuals have been nominated for election to the board, including Scott M. Brinker, Katherine M. Sandstrom, and others.
Executive compensation and say-on-pay
Shareholders are asked to provide advisory approval of executive compensation for 2025.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Healthpeak Properties
- Earnings and guidance rose on Janus Living IPO, senior housing gains, and major JV proceeds.DOC
Q2 2026 - All director nominees and proposals passed with a 91% quorum and no shareholder questions.DOC
AGM 2026 - 2026 guidance raised after Janus Living IPO, strong leasing, and robust capital actions.DOC
Q1 2026 - 2025 saw strong results, board refreshment, and enhanced ESG, with key votes on directors, pay, and auditor.DOC
Proxy Filing - Janus Living IPO and operational efficiencies position Healthpeak for growth in core healthcare real estate.DOC
Citi’s Miami Global Property CEO Conference 2026 - Janus Living IPO, $600M biotech campus acquisition, and $1B capital recycling drive growth.DOC
Investor presentation - 2026 guidance anticipates lab headwinds, but growth is driven by Outpatient and Senior Housing.DOC
Q4 2025 - Q2 2025 saw strong NOI growth, higher AFFO/FFO, and robust liquidity.DOC
Q2 2025 - Q1 2025 delivered strong earnings growth, robust leasing, and reaffirmed 2025 guidance.DOC
Q1 2025